Skip to main content

Breastfeeding, Avoiding Sugary Drinks Reduce Later Obesity Risk in Offspring

Medically reviewed by Carmen Pope, BPharm. Last updated on March 18, 2025.

By Lori Solomon HealthDay Reporter

TUESDAY, March 18, 2025 -- Adequate breastfeeding (BF) and avoidance of sugary beverages in early life may reduce the risk for preadolescent obesity in infants exposed to gestational diabetes (GDM), according to a study published online March 12 in Obesity.

Baiyang Sun, Ph.D., from Kaiser Permanente Northern California in Pleasanton, and colleagues evaluated the impact of fetal exposure to GDM severity, infant BF, and sugary beverage intake on preadolescent overweight and obesity. The analysis included 850 mother-infant dyads exposed to GDM.

The researchers found that among preadolescents (aged 6 to 11 years), 17.6 percent had overweight, 18.2 percent had moderate obesity, and 7.6 percent had severe obesity. Compared with adequate BF and no sugar-sweetened beverages [SSB] and 100 percent fruit juice [FJ], the risk for obesity was higher for both inadequate BF with SSB/FJ intake (adjusted relative risk [aRR], 1.55) and for adequate BF with SSB/FJ intake (aRR, 1.50), independent of GDM severity and covariates. The risk for severe obesity was more than tripled with inadequate BF with SSB/FJ intake versus adequate BF without SSB/FJ intake (aRR, 3.80).

"BF adequacy and avoidance of sugary beverages in early life are modifiable lifestyle behaviors that may combat preadolescent obesity in infants exposed to GDM, suggesting potential longer-term benefits on child cardiometabolic health," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted March 2025

Read this next

In Pediatric Leukemia, Survival Linked to Duration of Overweight, Obesity

TUESDAY, May 20, 2025 -- For children with acute lymphoblastic leukemia (ALL), longer duration of overweight or obesity is associated with lower overall and event-free survival...

GLP-1 Receptor Agonists Not Linked to Increased Risk of Psychiatric Adverse Events, Depression

MONDAY, May 19, 2025 -- For patients with overweight/obesity and/or diabetes, glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment is not associated with an increased...

Risk of Obesity-Related Cancer Similar for GLP-1 Receptor Agonists and Bariatric Surgery

THURSDAY, May 15, 2025 -- Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may cut the risk of obesity-related cancer (ORC) in patients being treated for diabetes and...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.